iXensor, the pioneer of mobile health, announces today that its PixoTest® POCT COVID-19 Antigen Test has received the CE-IVD mark. iXensor provides the end-to-end fully digitalized solution to prevent further outbreaks. iXensor’s PixoTest® solution comprises a palm-sized analyzer that reads test results accurately, a digital health pass App, an Admin…

TAIPEI, TAIWAN; – May 20, 2021 –  iXensor Co., Ltd. (6734.TWO) Dr. Carson Chen, CEO of iXensor, today participated in Johnson & Johnson Innovation’s webinar “The Future of Pandemic Prevention: Innovation Ecosystem Collaboration” together with renowned experts including Rick Bright (SVP Pandemic Prevention and Response at Rockefeller Foundation, former director…

iXensor, the pioneer of mobile health, is set to launch its end-to-end digital COVID-19 rapid antigen test solution that digitizes the entire user journey from screening, reporting to access control to combat outbreaks. The clinical performance evaluation has demonstrated superior accuracy of the PixoTest® POCT COVID-19 Antigen Test. The test…

While the current COVID-19 pandemic keeps impacting us globally, this will hardly have been the last pandemic of our times. What can we do to be better prepared or even prevent it from happening, though? Join our CEO, Dr. Carson Chen, as he discusses this timely topic together with other…

While most major economies continue to strive against rising infections and deaths caused by the novel coronavirus, Taiwan has set itself up for an economic revival due to its successful pandemic control measures. The CEO of iXensor,Carson Chen, invited by the Society for Promotion of East West Knowledge Transfer, gave…

iXensor, the pioneer of mobile health, infuses its corporate DNA of digital savviness into its upcoming product launch in January 2021. The PixoTest® COVID-19 Antigen Test, together with the PixoTest® POCT Analyzer, can yield positive results objectively in as short as 5 minutes through computer-aided analysis, minimizing the chances of…

iXensor announced today that, effective December 1st, it has become a resident of Johnson & Johnson Innovation – JLABS @ Shanghai. This is an important step toward further accelerating its PixoTech platform development and smartphone-based testing applications for new disease areas, leveraging JLABS’ global network and resources.   Johnson Innovation…

TAIPEI, TAIWAN / SINGAPORE – November 25th, 2020 – iXensor Co., Ltd. (6734.TWO)    Backed by two pharmaceutical giants Roche, Sanofi and organized by Plug and Play, the Startup Creasphere Program selected iXensor to join its three-month digital health accelerator program, which aimed for transforming healthcare together. In this first…